Related Experiment Videos
Human hepatitis B virus enhancer 1 is responsive to human interleukin-6
H Ohno1, S Kaneko, K Kobayashi
1First Department of Internal Medicine, Faculty of Medicine, Kanazawa University, Ishikawa, Japan.
Journal of Medical Virology
|August 1, 1997
Summary
Interleukin-6 (IL-6) boosts hepatitis B virus (HBV) enhancer activity via indirect NF-IL6 binding. This finding suggests a mechanism for controlling HBV X expression and viral replication in infected livers.
Area of Science:
- Hepatology
- Molecular Virology
- Immunology
Background:
- Serum levels of interleukin-6 (IL-6) are elevated in hepatitis B patients.
- IL-6 is a key inflammatory cytokine implicated in various liver diseases.
Purpose of the Study:
- To investigate the effect of IL-6 and its transcription factor NF-IL6 on hepatitis B virus enhancer 1 (Enh1) activity.
- To elucidate the mechanism by which IL-6 influences HBV Enh1 and potentially HBV X expression.
Main Methods:
- CAT assay to measure enhancer activity in HepG2 cells.
- Site-directed mutagenesis to identify critical cis-elements within Enh1.
- Electromobility shift assays (EMSA) to detect protein-DNA complex formation.
Main Results:
- IL-6 significantly increased Enh1 activity in HepG2 cells.
- Mutations in AP-1-related and C-stretch sites abolished IL-6-mediated enhancement.
- NF-IL6 expression also enhanced Enh1 activity, suggesting its involvement.
- EMSA confirmed increased complex formation with Enh1 upon IL-6 or NF-IL6 treatment.
- Competition assays indicated indirect binding of NF-IL6 to Enh1.
Conclusions:
- IL-6 enhances HBV Enh1 activity through signal transduction pathways involving indirect NF-IL6 binding.
- This mechanism may play a role in regulating HBV X expression and viral replication.
- Targeting the IL-6/NF-IL6 pathway could be a potential therapeutic strategy for hepatitis B.